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Abstract
An important outcome of any clinical intervention is the change in the subject's own perceived state
of health. This can be categorized as health-related quality of life (HRQL), utility (preference-based
health state), and daily life performance. 174 Swedish subjects with chronic obstructive pulmonary
disease (COPD) (mean age 64.3 ± 12 years) completed five self-administered questionnaires: Short
Form 36 (SF-36), St George's Respiratory Questionnaire (SGRQ), EuroQol-5D (EQ-5D), Health
States-COPD (HS-COPD), and Work Productivity and Activity Impairment Questionnaire for
COPD (WPAI-COPD). The subjects scored these outcomes instruments for ease of completion
using a 5-point scale. The time taken to complete them was noted and the administrators' opinion
of the subjects' comprehension of the questionnaires recorded using a 4-point scale.
A score of 1–3 ("very easy" to "acceptable") was recorded by 92% of subjects for the SF-36, 90%
for SGRQ, 80% for EQ-5D, 83% for WPAI-COPD, and 53% for HS-COPD. The HS-COPD was
graded "very difficult" to complete by 21% of subjects compared with 3–5% of subjects for the
other questionnaires. The mean time taken to complete all questionnaires was 39 minutes, and the
large majority of subjects scored "good" for understanding by the administrator. Age correlated
significantly with the degree of the subject's opinion of the ease of completion of five outcomes
instruments, while the influence of gender, socio-economic status and disease severity was not
statistically significant.
Introduction
Chronic obstructive pulmonary disease (COPD) is a pro-
gressive and largely irreversible airways disease character-
ized by emphysema and chronic bronchitis, resulting in
breathlessness, cough and sputum. As the disease
progresses, subjects with COPD experience increasing
deterioration of their health-related quality of life
(HRQL), with greater impairment in their ability to work
and declining participation in social and physical
activities.
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COPD is currently the fourth leading cause of death in the
US and its incidence is increasing [1]. Typically, COPD
affects today middle-aged to elderly men with significant
smoking histories. As a result of changing smoking habits,
the incidence of COPD in women is rapidly increasing
[2]. Respiratory diseases are among the three principal
causes of lost working days worldwide and COPD is
responsible for the majority of the loss [3].
HRQL, utility, and productivity impairment outcomes
instruments are increasingly used in clinical studies.
Although their use is established in many fields, such as
the gastrointestinal and oncology fields, questionnaires
are rarely used as primary endpoints in clinical studies of
respiratory disease. The European Agency for the Evalua-
tion of Medicinal Products (EMEA) states that, in clinical
studies of COPD, symptomatology should be a primary
endpoint, and the use of a disease-specific HRQL ques-
tionnaire is recommended [4]. Several disease-specific
and generic questionnaires suited to the respiratory field
have been developed in recent years.
Instruments to measure health outcomes
The Short Form 36 (SF-36) and St George's Respiratory
Questionnaire (SGRQ) are generic and disease-specific
HRQL questionnaires, respectively [5], [6]. The SF-36 has
been used in a number of therapeutic areas including
COPD. The SF-36 includes 36 items in 8 domains; Physi-
cal Functioning, Role Physical, Bodily Pain, General
Health, Vitality, Social Functioning, Role Emotional and
Mental Health. Two component summary scores are used,
the Physical Component Summary (PCS) and the Mental
Component Summary (MCS). The SGRQ has been widely
used in both COPD and asthma research and includes 56
items (76 weighted responses) across three domains,
symptoms, activity and impact.
The EuroQol-5D (EQ-5D) and Health States-COPD (HS-
COPD) are generic and disease-specific utility measures,
respectively. Utility measures are preference-based meas-
ures of health-related quality of life. These measures can
be used in economic evaluations [7]. Generally, these
measures evaluate subjective preferences for multi-dimen-
sional HRQL on a scale of 0 to 1 (or 100), where 0 usually
represents worst possible health and 1 (100) represents
perfect health [8], [9]. EQ-5D has been used in a number
of therapeutic areas. EQ-5D includes a vertical rating scale
from 0 to 100 and in addition five items including mobil-
ity, self-care, usual activity, pain/discomfort and anxiety/
depression [10]. The HS-COPD is still under development
(personal communication, Gordon Guyatt, McMaster
University, Hamilton, Canada) although a preliminary
version, tested both in Canada and Sweden, is available.
Also the HS-COPD includes a vertical rating scale ranging
from 0 (worst possible health-state) to 100 (best possible
health-state). Three pre-defined health marker states are
to be indicated on the rating scale by the subjects. The sub-
jects then register their own health state using the same
scale. The pre-defined health marker states are drafted as
narratives with extensive information but are considered
as a guide for subjects and are not used in analyses.
The Work Productivity and Activity Impairment Ques-
tionnaire for COPD (WPAI-COPD) is a productivity and
activity impairment instrument covering seven items on
the limitations that impact on work and daily activity. It
has been applied in some therapeutic areas, such as rhin-
itis and gastroenterology [11], [12].
Evidence suggests that the indirect assessment of a sub-
ject's HRQL, via relatives, care providers or health profes-
sionals, tends to underestimate the level of HRQL
impairment [13], [14] and is thus preferable for the sub-
jects to be assessed directly. At present, no data have been
published to describe whether subjects with COPD have
difficulty completing self-administered questionnaires.
Such data on burden of completion are important in eval-
uating the feasibility of these assessments in clinical stud-
ies of COPD and for the interpretation of results.
The present study investigated the ease/difficulty of com-
pletion as well as the time of completion of the five out-
comes instruments, including the two HRQL
questionnaires, the two utility questionnaires and the pro-
ductivity/activity questionnaire by subjects with COPD.
Material and methods
The study was performed in a three-month period during
the winter of 2000. The study was approved by the Ethics
Committee of the University Hospital of Northern Swe-
den in Umeå.
Study sample
The study sample has been described in previous publica-
tions and was used in a recently completed study of cost-
of-illness [15] and a study of exacerbations [16]. In sum-
mary, the sample was derived from large-scale population
studies of the epidemiology of obstructive airway diseases
in Northern Sweden, the OLIN studies. Longitudinal stud-
ies of a number of cohorts are in progress since 1985,
today including approximately 40,000 people of the gen-
eral population, including also children and elderly [15].
The inclusion criterion, a diagnosis of COPD, was based
on spirometry tests. This diagnosis was defined according
to the British Thoracic Society's (BTS) criteria; FEV1 /VC
ratio <70% and FEV1 <80% of predicted values, and fur-
thermore, due to the FEV1, divide COPD into mild, mod-
erate and severe disease [17]. In addition, persons with an
FEV1 /VC ratio <70% and an FEV1 ≥ 80% of the predictedHealth and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/18
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value were also included in the study. The inclusion of
this mild type of COPD is fully in agreement with the
recent Global Initiative of Chronic Obstructive Pulmo-
nary Disease (GOLD) guidelines [18].
When stratifying by age, range 28–80 years, and disease
severity, some strata contain a low number of subjects.
Thus, all subjects having FEV1 < 60% of predicted were
included in the study sample, and for subjects with an
FEV1 ≥ 60% of predicted, a random sample was drawn
from each stratum.
The study sample is shown in Table 1. Of the 202 invited,
174 (70 women) participated, which corresponds to 86%
of the invited. All but one completed all five question-
naires. One subject completed only the first three ques-
tionnaires (SF-36, SGRQ and EQ-5D).
Three categories of socio-economic groups were included.
The first category was manual workers in industry and in
service (n = 78). The second category was non-manual
employees and included intermediates, civil servants and
professionals (n = 60). The last category comprised all
others, including unemployed and housewives (n = 36).
Of the 138 'employees', 65 were still working but 73 had
retired, of whom 40 had retired early.
The mean FEV1 of the subjects was 1.76 ± 0.78 L (range
0.46.– 4.12 L) and 62 ± 20% of predicted normal value
(range 18. – 118%). Using the FEV1 classification from the
GOLD guidelines, 19 subjects were categorized as being in
stage I, 'mild' COPD (FEV1 ≥ 80% pred.), 82 subjects were
in stage IIA, 'moderate' COPD (FEV1 50–79% pred.), 32
subjects were in stage IIB, 'moderate' COPD (FEV1 30–
49% pred.), and 9 subjects were in stage III 'severe' COPD
(FEV1 <30% pred.) [18].
Methods
An initial, brief instruction from the administrator, an
appointed nurse, was given to all subjects including the
following information: all questionnaires should be com-
pleted in the given order, no explanation of any question
would be given and if a question was not understood, the
subjects were told to go to the next question. All question-
naires were completed, unaided, by all subjects in the
same and following order: SF-36, EQ-5D, SGRQ, WPAI-
COPD and HS-COPD. This order was chosen on the basis
of the recommendation that generic measures, such as SF-
36 and EQ-5D, should be completed before disease-spe-
cific measures, such as SGRQ and HS-COPD, and that
HRQL measures should be completed before utility meas-
ures. Since EQ-5D and HS-COPD both use a similar rating
scale, the WPAI-COPD questionnaire was scheduled
between these two questionnaires.
Subjects scored questionnaires for ease/difficulty of com-
pletion on a scale of 1–5 (1 = very easy, 2 = easy, 3 =
acceptable, 4 = difficult and 5 = very difficult) (Table 2).
In addition, the administrator gave her opinion of how
she felt about the subjects' comprehension of the instru-
ments using a 4-point scale (1 = good understanding, 2 =
probably understood, 3 = possibly understood and 4 =
did not understand) (Table 2). The time taken by subjects
to complete all of the outcomes instruments was also
recorded by the administrator.
Table 1: Subject characteristics
Number 174
Women / men 70 / 104
Age, years
Mean ± SD 64.3 ± 12
Range 28–80
FEV1, L
Mean ± SD 1.76 ± 0.78
Range 0.46 – 4.12
FEV1, % pred
Mean ± SD 62 ± 20
Range 18–118
GOLD classification
Number of subjects:
Stage I 19
Stage IIA 82
Stage IIB 32
Stage III 9Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/18
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Analysis
Data were analysed using a linear model with factors for
gender, disease severity and socio-economic group and
with age as covariate. Trend for disease severity was tested
by use of a linear contrast.
The Global Initiative for Chronic Obstructive Lung Dis-
ease (GOLD) guidelines were used for classification of dis-
ease severity [18].
Results
A score of 1–3 ("very easy" to "acceptable") was recorded
by 92% of the subjects for SF-36, by 90% for SGRQ, by
83% for WPAI-COPD, 80% for EQ-5D, and by 53% for
HS-COPD. Ten to fifteen percent of the subjects found SF-
36, SGRQ or EQ-5D "very easy" to complete, with only 3–
4% finding these questionnaires "very difficult" to com-
plete (Table 3). The administrator's opinion of the sub-
jects' understanding was generally good, with only 2
subjects graded as having "not understood" (Table 4).
Table 2: Question to the subject
A. You have now completed 5 various questionnaires
Please indicate on a rating scale scored 1–5 the degree of difficulty to complete them:
1 = very easy 2 = easy 3 = acceptable
4 = difficult 5 = very difficult
1) SF-36 ____
2) SGRQ ____
3) EQ-5D ____
4) WPAI ____
5) HS-COPD ____
To be completed by administrator.
B. Time for completion: ____ min
C. The administrator's opinion of how the subject understands the meaning of the questionnaires
Good understanding (1)
Probably understood (2)
Possibly understood (3)
Did not understand (4)
Table 3: Subjects' scorin g of questionnaires
Questionnaire (n) Score
Very easy (1) Easy (2) Acceptable (3) Difficult (4) Very difficult (5)
n (%) n (%) n (%) n (%) n (%)
SF-36 (174) 26 (15) 80 (46) 54 (31) 9 (5) 5 (3)
SGRQ (174) 22 (13) 79 (45) 55 (32) 13 (7) 5 (3)
EQ-5D (174) 18 (10) 70 (40) 51 (29) 28 (16) 7 (4)
WPAI-COPD (173) 22 (13) 79 (46) 43 (25) 17 (10) 12 (7)
HS-COPD (173) 8 (5) 34 (20) 49 (28) 46 (27) 36 (21)
Table 4: Subjects' understanding according to the administrator
Score Good understanding (1) Probably understood (2) Possibly understood (3) Did not understand (4)
n (%) 118 (68%) 40 (23%) 14 (8%) 2 (1%)Health and Quality of Life Outcomes 2003, 1 http://www.hqlo.com/content/1/1/18
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The results demonstrate that older subjects have more dif-
ficulties completing the questionnaires. The test for trend
in difficulty was statistically significant for all question-
naires when all groups were compared: SF-36 p = 0.003,
SGRQ p < 0.001, EQ-5D p < 0.001, WPAI-COPD p <
0.001, and HS-COPD p < 0.001. Data from the six age
groups and SF-36, SGRQ and EQ-5D are shown in figure
1.
The severity of COPD also influenced the difficulty expe-
rienced by subjects in completing questionnaires (Figure
2). Although higher scores were seen for increasing
severity, the trend was not statistically significant after cor-
rection for other factors included in the model.
Female subjects reported greater difficulty completing all
five outcome instruments than male subjects did. How-
ever, the gender difference was statistically significant only
for the EQ-5D (43% of the women scored 1 and 2 com-
pared with 57% of the men, p = 0.026). The three socio-
economic groups did not show any significant differences
for any of the comparisons made in this study. The scores
1 or 2 of ease of completion of SF-36 were as follows:
manual employees 50%, non-manual-employees 77%,
and unemployed 58%. For the SGRQ the values were:
manual employees 58%, non-manual employees 68%,
and unemployed 42%. Similar values were recorded for
the other three instruments. Nominal differences were
seen but without statistical significance.
The recorded mean time for completion of all five ques-
tionnaires was 39 ± 13 minutes (range 10–80 minutes).
There was also a tendency that the disease severity affects
the subject's need of time to complete the questionnaires.
However, 95% of the subjects completed the question-
naires within one hour.
Discussion
In clinical research and in daily life, subjects are often
required to complete questionnaires. The ability to under-
stand and complete these forms correctly has not been
studied to any great extent. Today COPD is a progressive
condition, most prevalent in older men of low socio-eco-
nomic status. Thus, the impact of age, disease severity,
gender, and socio-economic status on the ability of sub-
jects with COPD to complete a battery of questionnaires
has relevance. The present study identified how subjects
experience the difficulty of completing a number of well-
used as well as new questionnaires. The number of ques-
tionnaires was high, however, in clinical research it may
happen that more than two questionnaires are included.
Compliance by subjects in this study was very high (only
one subject failed to complete all questionnaires), proba-
bly due to careful and detailed counselling of subjects.
Other studies have reported considerably poorer compli-
ance, with illiteracy, visual impairment, poor physical and
mental condition, and refusal cited as influencing factors
[19].
Subjects consistently found the HS-COPD questionnaire
more difficult to complete than the other questionnaires.
Reasons for this may be the complexity of the question-
naire or subject fatigue. HS-COPD was the last of five
Figure 1
Subjects' mean scoring by age groups (according to the 
cohort of subjects included)
Subjects' average scoring by age group 
0
1
2
3
4
5
SF-36 SGRQ EQ-5D
Score
<45
49-50
58-59
64-65
73-74
79-80
Age
Easy
Score: 1 = very easy, 2 = easy, 3 = acceptable, 4 = difficult, 5 = very difficult
p=0.003 p<0.001 p<0.001
Figure 2
Subjects' mean scoring according to severity of COPD 
(GOLD criteria: FEV1 % predicted normal values, ≥ 80% = 
Stage I mild, 50. – 79% = Stage IIA moderate, 40. – 49% = 
Stage IIB moderate, <30% = Stage III severe)
Subjects' average scoring according to severity of COPD
0
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SF-36 SGRQ EQ-5D WPAI-
COPD
HS-
COPD
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questionnaires completed by the subjects. In retrospect,
the order of the questionnaires should maybe have been
given in a randomized order to prevent a possible tired-
ness when completing the last questionnaire. However, in
the present study we chose the same order to all subjects.
One reason for doing so was that the common use of
questionnaires in clinical research is in the same order.
Otherwise the results of the assessments may differ.
However, with the aim of this study, a randomized order
would have been recommended.
The HS-COPD utility measure is still under development
and may need some refinement before it can be adminis-
tered and completed with ease in future clinical studies
(personal communication, Gordon Guyatt).
The majority of the subjects taking part in this study was
considered by the study nurse to have a good understand-
ing of the questionnaires, and was able to complete them
quickly and without difficulty. Despite this, certain issues
did become apparent. Age appeared to correlate with the
degree of difficulty experienced by subjects to complete
these outcomes measures. The increasing incidence of
concomitant diseases in the elderly with increasing age
may influence their reading, writing, or cognitive abilities,
and may explain the correlation. Disease severity proba-
bly also affects the ease of completing the outcomes
instruments and this may be related to the subject's phys-
ical condition.
Gender differences identified in this study could not easily
be explained, however, a statistically significant difference
was only noticed for one questionnaire, the EQ-5D.
Unlike previous studies, no statistically significant differ-
ences between socio-economic groups were observed
[20]. In Sweden, the great majority of the population has
quite good reading skills.
Health-related quality of life, utility and productivity out-
come instruments have an important role to play in the
assessment of the general well-being of subjects with
COPD. The ease with which these questionnaires can be
understood and completed is pertinent to issues of com-
pliance and therefore of accuracy in assessing the impact
of this progressive, chronic disease. The importance of
completing questionnaires in a reasonably short time
should be highlighted. The burden of the subjects, as well
as the burden of the clinic, can be high if a subject should
need more than one hour to complete questionnaires. In
the present study, the large majority of the subjects with
COPD succeeded to complete the questionnaires during a
relatively short time: 95% needed 26–52 minutes totally
for all 5 questionnaires.
In conclusion, the correlation of age with difficulty in
completing questionnaires needs to be a consideration
when using such measures in clinical studies of COPD.
Disease severity may also affect the ease of completion.
Further research in a large population is needed to have
confidence of the collected data on subjects' ease of com-
pletion of outcomes instruments.
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